Cancer Diagnosis News and Research

RSS

Reducing testing disparities could dramatically cut colon cancer rates among Black Americans

A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, finds that eliminating the race disparity in colon cancer testing in the United States would reduce colon cancer, and colon cancer death rates, dramatically among Black people.

24 Jul 2024

AI model Virchow outperforms clinical methods in cancer detection

In a recent study published in Nature Medicine, researchers demonstrated the use of the foundational model Virchow for computational analysis of pathological reports, prediction of biomarkers, and identification of cells across multiple cancer types. Virchow's pan-cancer model showed impressive accuracy, often outperforming clinical-grade models.

23 Jul 2024

Study validates Stockholm3 test for prostate cancer in ethnically mixed populations

Stockholm3, a prostate cancer test developed in Sweden, runs a combination of protein and genetic markers from a blood sample through an algorithm to find the probability of a patient having clinically significant cancer.

23 Jul 2024

Stockholm3 blood test proves effective at detecting prostate cancer in different ethnic groups

The Stockholm3 blood test, developed by researchers at Karolinska Institutet in Sweden, is equally effective at detecting prostate cancer in different ethnic groups, a new paper published in The Journal of Clinical Oncology reports.

22 Jul 2024

Research highlights green tea's potential role in improving ovarian cancer outcomes

The association between pre-diagnosis tea and coffee consumption and survival rates in women diagnosed with ovarian cancer.

18 Jul 2024

An Arm and a Leg: The woman who beat an $8,000 hospital fee

Hospital facility fees. They can feel like a charge just for walking in the door. Hospitals say they go toward overhead on facilities with lots of specialized equipment and staff, like emergency rooms.

17 Jul 2024

Hormone modulating therapy may lower dementia risk in breast cancer survivors

Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study published today in JAMA Network Open.

16 Jul 2024

40% of US cancer cases linked to lifestyle choices

Nearly 40% of cancer cases and 44% of cancer deaths in 2019 were due to modifiable risk factors, with cigarette smoking as the leading cause. This study highlights the potential to significantly reduce cancer burden through lifestyle changes.

14 Jul 2024

Poll: Majority of Brits fear cancer diagnosis more than any other condition

Two-thirds of the public say they are very or somewhat worried about being told they have the disease – higher than for any other medical condition, including dementia and having a heart attack – according to polling released today.

14 Jul 2024

Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

A recent European Urology Oncology study assessed the mortality risks, based on the Gleason score and clinical parameters, in patients with prostate cancer.

11 Jul 2024

Mediterranean diet linked to enhanced longevity, reduced cardiovascular mortality in cancer survivors

The Mediterranean Diet is a powerful ally for health even after a cancer diagnosis. This is the key result of an Italian study carried out as part of the UMBERTO Project, conducted by the Joint Research Platform Umberto Veronesi Foundation - Department of Epidemiology and Prevention of the I.R.C.C.S. Neuromed of Pozzilli, in collaboration with the LUM "Giuseppe Degennaro" University of Casamassima (BA).

2 Jul 2024

Whole genome sequencing can improve clinical care of childhood cancer

Whole genome sequencing has improved clinical care of some children with cancer in England by informing individual patient care.

2 Jul 2024

Study exposes algorithmic inequity in endometrial cancer detection for Black women

A common algorithm to check for endometrial cancer is not reliable for Black women, according to a new study published today in JAMA Oncology.

27 Jun 2024

Bridging knowledge and confidence to increase skin self-examinations

It's summer and time to enjoy the sunshine. But it's also important to do so safely. Skin cancer is the most common form of cancer in the United States-;and it's most commonly caused by sun exposure.

24 Jun 2024

Nurse training key to improving cancer screening for transgender and gender diverse individuals

The lack of culturally safe health screening for people who are transgender and gender diverse (TGD) is putting them at greater risk of cancer going undetected, but nurse practitioners could be trained to help close the gap.

22 Jun 2024

UT Health Science Center awarded $1.58M grant to study cancer disparities among Black women

A $1.58 million grant will support work by a health communication scholar at the University of Tennessee (UT) Health Science Center's College of Nursing and a medical oncologist at West Cancer Center and Research Institute (WCCRI) to identify sociocultural and structural factors that are root causes of cancer health disparities for Black women in the Mid-South.

20 Jun 2024

Noninvasive urine test enhances early detection of bladder cancer in patients with hematuria

One of the first signs of bladder cancer can be blood in the urine (hematuria). Investigators developed and analyzed the results of a streamlined and simplified DNA-based urine test to improve the accuracy of early detection of bladder cancer in patients with hematuria.

20 Jun 2024

Super Surgeons: A Chance at Life returns with new season on Channel 4

Series two of Wonderhood’s Super Surgeons: A Chance at Life will air on 18 June, giving viewers exclusive behind-the-scenes access to The Royal Marsden NHS Foundation Trust, a world-leading comprehensive cancer center.

19 Jun 2024

Innovative 3D cell culturing method offers new insights into cancer cell mechanics

Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials.

14 Jun 2024

Stanford study finds low risk of secondary blood cancers after CAR-T cell therapy

A large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell therapy -; a cell-based cancer treatment that exploded on the scene in 2017 as a treatment for intractable blood cancers -; is low, despite a Food and Drug Administration warning.

12 Jun 2024